Cargando…
Effects of fecal microbiota transplantation in metabolic syndrome: A meta-analysis of randomized controlled trials
OBJECTIVE: The prevalence of obesity and type 2 diabetes is rapidly increasing worldwide, posing serious threats to human health. This study aimed to evaluate the role of FMT in the treatment of obesity and/or metabolic syndrome and its impact on clinically important parameters. METHODS: We searched...
Autores principales: | Qiu, Bo, Liang, JiaXu, Li, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358997/ https://www.ncbi.nlm.nih.gov/pubmed/37471410 http://dx.doi.org/10.1371/journal.pone.0288718 |
Ejemplares similares
-
Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial
por: da Ponte Neto, Alberto Machado, et al.
Publicado: (2023) -
Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Wu, Jie, et al.
Publicado: (2022) -
Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials
por: Samuthpongtorn, Chatpol, et al.
Publicado: (2022) -
Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Zhao, Hui-jun, et al.
Publicado: (2022) -
A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease
por: Tan, Xi-Yue, et al.
Publicado: (2022)